Prognostication of long-term outcomes for patients with ischemic heart disease

Jelena Umbrasienė1, Edita Jankauskienė, Nora Kupstytė

  • 1Department of Cardiology, Medical Academy, Lithuanian University of Health Sciences, Eivenių 2, 50028 Kaunas, Lithuania. jelena0110@yahoo.com

Insights

This study identified key predictors of one-year mortality in patients with acute and chronic coronary syndromes. Age, stroke history, and heart failure severity were critical for acute cases, while reduced heart function and elevated heart rate predicted mortality in chronic cases.

Area of Science:

  • Cardiology
  • Public Health
  • Geriatrics

Background:

  • Cardiovascular disease, including coronary heart disease (CHD), is a leading cause of death in European elderly adults.
  • Clinical data collection for acute and chronic coronary syndromes began in 2005 at the Clinic of Cardiology, Lithuanian University of Health Sciences.
  • The study aimed to assess one-year mortality risk in patients treated for coronary syndromes.

Purpose of the Study:

  • To evaluate one-year mortality after inpatient treatment for acute and chronic coronary syndromes.
  • To identify risk factors influencing mortality in different patient groups.
  • To develop a risk assessment tool for clinicians.

Main Methods:

  • A cohort of 3268 patients treated for coronary heart disease (acute myocardial infarction, unstable angina, stable angina) in 2005 was randomly selected.
  • Standardized questionnaires were used to collect clinical data.
  • One-year follow-up re-examinations were conducted on 1908 patients to assess outcomes.

Main Results:

  • For acute coronary syndromes, mortality was significantly influenced by age (70-80 years), history of stroke, Killip class III-IV, and low high-density lipoprotein cholesterol.
  • For chronic coronary syndromes, reduced ejection fraction (<40%) and increased heart rate (>70 bpm) were the strongest predictors of one-year mortality.

Conclusions:

  • A scoring system was developed to assess one-year mortality risk for patients with acute and chronic coronary syndromes.
  • This tool can aid cardiologists and family physicians in risk evaluation for both inpatient and outpatient settings.
  • The findings contribute to improved patient management and risk stratification in cardiovascular care.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...